Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB).

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

Orchestra BioMed (Nasdaq:OBIO) today announced the pricing of an underwritten public offering totaling proceeds of ...

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Rhythm (Nasdaq: IRTC) announced a strategic partnership with Lucem Health to accelerate undiagnosed arrhythmia detection.

Baxter (NYSE: BAX) + shares fell sharply today on second-quarter results that came up shy of the consensus forecast. Shares ...

Stryker will increase its full-year guidance after a Street-beating second quarter that saw strong demand for products and continued business momentum.

Vicarious Surgical (NYSE:RBOT) announced today that it appointed Stephen From as CEO, effective Aug. 7, 2025. Adam Sachs, ...

Resmed (NYSE: RMD) today reported second-quarter financial results that came in ahead of the consensus Wall Street forecast.

Integra LifeSciences (Nasdaq: IART) shares are on the rise today on second-quarter results that beat the consensus forecast.

Sava Technologies could be bringing another glucose biosensor to the competitive continuous glucose monitor (CGM) market.

Last year was the first year that Drug Delivery Business News published a list of the world’s largest diabetes tech companies ...